Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and ...

Declining health outcomes in rural Missouri are getting worse after Anthem Blue Cross and Blue Shield failed to agree with University of Missouri Health Care on higher reimbursement rates for patient ...

A total of 8 analyst ratings have been received for Elevance Health, with the consensus rating being Outperform. The average ...

For full-year 2024, Elevance reported $175.2 billion in revenue, an increase of 2.9% over its $170.2 billion haul in 2023.

Fintel reports that on April 15, 2025, Baird downgraded their outlook for Elevance Health (NYSE:ELV) from Outperform to ...

We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to take a look at where ...

Baird notes Elevance Health (ELV) pre-announced a Q1 earnings beat with adjusted EPS of $11.97 vs. $11.62 implied guide, vs. $11.32 street, vs. its $11.63. The company cites medical costs ...

Elevance Health will beat its earnings guidance for the first quarter despite high Medicare Advantage costs, the company announced Thursday. The health insurer reported that while Medicare ...

Elevance Health’s payout ratio is presently 26.71%. Several large investors have recently made changes to their positions in the stock. Accredited Wealth Management LLC acquired a new position ...

Elevance Health (NYSE:ELV) on Thursday issued its preliminary financial results for Q1 2025, projecting $9.61 of GAAP net income and $11.97 of non-GAAP net income on a diluted per share basis ...

But Elevance Health ... is to compare the change in the earnings per share (EPS) with the share price movement. During five years of share price growth, Elevance Health achieved compound earnings ...